{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:33:02Z","timestamp":1791340382698,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"AstraZeneca K.K."}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ekir.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T23:28:15Z","timestamp":1559172495000},"page":"1248-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan"],"prefix":"10.1016","volume":"4","author":[{"given":"Naoki","family":"Kashihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2019.05.018_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1313341","article-title":"An integrated view of potassium homeostasis","volume":"373","author":"Gumz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib3","first-page":"43","article-title":"Potassium-binding agents for the clinical management of hyperkalemia","volume":"41","author":"Chaitman","year":"2016","journal-title":"P\u00a0T"},{"key":"10.1016\/j.ekir.2019.05.018_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/aoms.2014.42577","article-title":"Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes","volume":"10","author":"Khanagavi","year":"2014","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ekir.2019.05.018_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin\u2013angiotensin\u2013aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.amjmed.2015.05.040","article-title":"Management of hyperkalemia: an update for the internist","volume":"128","author":"Kovesdy","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib7","first-page":"418","article-title":"Higher serum potassium level associated with late stage chronic kidney disease","volume":"34","author":"Hsieh","year":"2011","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.ekir.2019.05.018_bib8","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: predictors of mortality","volume":"16","author":"An","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ekir.2019.05.018_bib9","first-page":"65","article-title":"Incidence, predictors, and outcome associations of dykalemia in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"7","author":"Savarese","year":"2019","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.ekir.2019.05.018_bib10","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1681\/ASN.2016121344","article-title":"How dangerous is hyperkalemia?","volume":"28","author":"Montford","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/03007995.2018.1433141","article-title":"The prevalence of hyperkalemia in the United States","volume":"34","author":"Betts","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ekir.2019.05.018_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2016.07.926","article-title":"Validation of the european SCORE risk chart in the healthy middle-aged Japanese","volume":"252","author":"Sawano","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2019.05.018_bib13","unstructured":"Ministry of Health, Labour and Welfare of Japan. Patient Survey 2014. Tokyo, Japan: Ministry of Health, Labour and Welfare of Japan."},{"key":"10.1016\/j.ekir.2019.05.018_bib14","first-page":"659","article-title":"Incidence of hyperkalemia in hospitalized patients","volume":"19","author":"Shemer","year":"1983","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.ekir.2019.05.018_bib15","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factor associated with hyperkalemia in predialysis patients in a low-clearlance clinic","volume":"7","author":"Sarafidis","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/dme.13687","article-title":"Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study","volume":"35","author":"Thomsen","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2019.05.018_bib19","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/ndt\/gfx312","article-title":"Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes\u2014a Danish population-based cohort study","volume":"33","author":"Thomsen","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2019.05.018_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.kisu.2016.01.004","article-title":"Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena","volume":"6","author":"Epstein","year":"2016","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2019.05.018_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renalprotective properties of ACE-inhibition in non-diabetic nephropathies with non-diabetic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2019.05.018_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects on losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intorelant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2019.05.018_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intorelant to angiotensin-converting enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2019.05.018_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.05.018_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrneph.2014.168","article-title":"Management of hyperkalemia in chronic kidney disease","volume":"10","author":"Kovesdy","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12882-018-1007-1","article-title":"Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink","volume":"19","author":"Furukand","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib31","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2016.06.060","article-title":"Hyperkalemia in heart failure","volume":"68","author":"Sarwar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2019.05.018_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"11 Suppl","key":"10.1016\/j.ekir.2019.05.018_bib33","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ekir.2019.05.018_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2019.05.018_bib35","first-page":"449","article-title":"Estimating medication persistecy using administrative claims data","volume":"11","author":"Sika","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ekir.2019.05.018_bib36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bone.2011.12.021","article-title":"Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan","volume":"50","author":"Wade","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2019.05.018_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00005650-200208000-00002","article-title":"Pharmacy data identify poor adherent patients with schizophrenia at\u00a0increased risk for admission","volume":"40","author":"Valenstein","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.ekir.2019.05.018_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2012.08.016","article-title":"Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review","volume":"126","author":"Harel","year":"2013","journal-title":"Am J Med"},{"issue":"Supplement A","key":"10.1016\/j.ekir.2019.05.018_bib39","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1093\/eurheartj\/suy035","article-title":"Pharmacology of new treatments for hyperkalemia: patiromer and sodium zirconium cyclosiliate","volume":"21","author":"Rosano","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.ekir.2019.05.018_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.ekir.2019.05.018_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.05.018_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/dc11-1864","article-title":"Socioeconomic status and mortality. Contribution of healthcare access and physical distress among U.S. adults with diagnosed with diabetes","volume":"36","author":"Saydah","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2019.05.018_bib44","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/S0140-6736(17)31634-3","article-title":"The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study","volume":"390","author":"Lear","year":"2017","journal-title":"Lancet"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802491930213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802491930213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:24:29Z","timestamp":1762831469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802491930213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S246802491930213X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2019.05.018","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}